Tirzepatide injection dosage: the schedule explained clearly

The biggest myth: higher doses are always better

A common assumption is that the goal of tirzepatide treatment is to reach 15 mg as fast as possible. This gets the purpose of the dosage schedule exactly backwards. The graduated steps exist primarily to manage tolerability, not to race towards a ceiling. Nausea, stomach discomfort and loose stools are most common when the body is adjusting to a new dose level; moving up too quickly increases that burden without meaningful added benefit for most people.

Clinical trial participants in the SURMOUNT programme (described in detail in the SURMOUNT-1 paper, published in the New England Journal of Medicine) followed this phased approach. The results attributed to the 15 mg group reflected a process of getting there carefully, not a shortcut. Some participants achieved significant weight reduction at doses below 15 mg. The prescriber's role is to find the highest dose you tolerate well, which may or may not be the maximum.

It is also worth knowing that tirzepatide works through two gut-hormone receptors (GIP and GLP-1), the only weight-management medicine licensed in the UK to do so. That dual mechanism influences appetite and gastric emptying. The dose schedule is calibrated to this pharmacology; it is not an arbitrary waiting game.

How the six strengths map onto a real treatment timeline

Under the licensed schedule, treatment starts at 2.5 mg for the first four weeks. This pen's job is adjustment; most people notice little in the way of appetite change at this stage, and that is by design. After four weeks, the prescriber typically moves the dose to the 2.5 mg starting pen into the next tier (5 mg) for another four-week period.

From there, the steps run 7.5 mg, 10 mg, 12.5 mg and finally 15 mg, each approximately a month apart. A full tirzepatide injection dosage chart would show six steps across roughly six months of titration, though in practice many people spend longer at a given strength if GI side effects need settling before moving on. You can read more about what each individual strength involves on the full tirzepatide doses overview.

Dose increases are not automatic. At nume, every repeat order goes through a clinical review (a real prescriber reads your update) before a higher-strength pen is dispensed. Evidence of how the current dose is being tolerated forms part of that assessment. This is consistent with the approach described in the NHS's patient information for tirzepatide, which notes that your doctor will usually increase the dose gradually.

What happens at 15 mg, and what if you stay lower?

Fifteen milligrams is the maximum strength in the licensed range. Reaching it is appropriate for people who tolerate the titration well and whose prescriber judges it clinically beneficial. It is not a target everyone needs to hit. Some people find that moving through strengths such as the 5 mg tirzepatide injection delivers the response they're looking for with fewer gastrointestinal side effects; staying there is a legitimate clinical outcome, not a compromise.

If you're curious about the highest-strength pen specifically, the 15 mg tirzepatide page covers what's known about its use. For a broader look at cost across the dose range, the Mounjaro pricing page sets out the context in one place.

One thing the dosage schedule cannot tell you is whether tirzepatide is appropriate for you at all, that requires a full clinical assessment. BMI, medical history, current medicines and other factors all feed into that picture. If you are pregnant, trying to conceive, or breastfeeding, tirzepatide is not recommended; the same applies to anyone under 18.

Missed doses, storage and the Patient Information Leaflet

There is one piece of honest guidance that sits outside the scope of this page: specific instructions for what to do if you miss a dose, how long the pen can be kept out of the fridge, and exactly when to take it relative to food. These are questions our prescribers hear often, and the answers genuinely vary by individual circumstance.

The authoritative source for the precise rules is the Patient Information Leaflet that comes with your pen, and the Mounjaro SmPC on the electronic Medicines Compendium (eMC) gives the full prescriber-facing detail. If you are unsure about any aspect of your current dose or schedule, the right move is to contact your prescriber rather than adjust anything on your own. At our pharmacy, prescriber aftercare is available seven days a week, a question about your dose does not have to wait until Monday.

If you are considering starting tirzepatide and want to understand how the dosage journey might look for you specifically, a free consultation with our clinical team is the place to begin.